CSIMarket
Gilead Sciences Inc   (GILD)
Other Ticker:  
 
 

Gilead Sciences Inc 's Yearly Net Income Growth 5 Years

 

Select the Comparisons : Select the Ratio:



GILD Annual Net Income Growth

2023
2022
2021
2020
2019
Y / Y Annual Net Income Change 22.93 % -26.37 % 6867.42 % -98.34 % -1.76 %
Annual Net Income (in millions $) $5,613.00 $4,566.00 $6,201.00 $89.00 $5,364.00


Annual Net Income Growth Comment
Gilead Sciences Inc 's Annual Net Income for the fiscal year ended 2023, jumped by 22.93% to $5,613.00 millions, from $4,566.00 millions achieved a year ago. Gilead Sciences Inc 's growrh rate for Net Income improved from -26.37 % decline in the fiscal year 2022.

Gilead Sciences Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual Net Income within Healthcare SectorY/Y Net Income Growth %2023 Annual Net Income
Pfizer Inc -93.13 %$ 2,158.000  millions
Johnson and Johnson  95.94 %$ 35,153.000  millions
Biontech Se -90.14 %$ 1,041.936  millions
Novartis Ag  113.57 %$ 14,854.000  millions
Biogen Inc -60.78 %$ 1,161.500  millions
Zoetis Inc   10.85 %$ 2,340.000  millions
Becton Dickinson And Company -16.58 %$ 1,484.000  millions
Takeda Pharmaceutical Company Limited  30.34 %$ 2,196.436  millions
Edwards Lifesciences Corporation -8.05 %$ 1,399.400  millions
Intuitive Surgical Inc   35.18 %$ 1,817.300  millions
Agilent Technologies inc -1.12 %$ 1,240.000  millions
Iqvia Holdings Inc   24.47 %$ 1,358.000  millions
Quest Diagnostics Inc -10.54 %$ 908.000  millions
Fresenius Medical Care Ag -18.10 %$ 820.353  millions
Tenet Healthcare Corp  30.97 %$ 1,311.000  millions
Organon and Co   11.56 %$ 1,023.000  millions
Mettler toledo International Inc -9.60 %$ 788.778  millions
Davita Inc   22.43 %$ 956.978  millions
Resmed Inc   15.15 %$ 897.556  millions
United Therapeutics Corporation  35.40 %$ 984.800  millions
Boston Scientific Corporation  128.08 %$ 1,592.000  millions
Idexx Laboratories Inc  24.44 %$ 845.042  millions
West Pharmaceutical Services Inc   1.28 %$ 593.400  millions
Revvity Inc   21.77 %$ 693.094  millions
Vir Biotechnology Inc